Imatinib (QTI571) in Pulmonary Arterial Hypertension
Completed · Phase 3 · Has a placebo group
Conditions studied: Pulmonary Arterial Hypertension
In brief
A multinational, multicenter, double blind, placebo-controlled study evaluating the efficacy and safety of imatinib as an add-on therapy in the treatment of patients with severe pulmonary arterial hypertension (PAH).
Key facts
- Study ID
- NCT00902174
- Run by
- Novartis Pharmaceuticals
- People needed
- 202
- Starts
- 2009-09-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2016-02-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Phoenix, Arizona, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — San Francisco, California, United States
- Novartis Investigative Site — Aurora, Colorado, United States
- Novartis Investigative Site — Clearwater, Florida, United States
- Novartis Investigative Site — Miami Beach, Florida, United States
- Novartis Investigative Site — Weston, Florida, United States
- Novartis Investigative Site — Atlanta, Georgia, United States
- Novartis Investigative Site — Chicago, Illinois, United States
- Novartis Investigative Site — Baltimore, Maryland, United States
- Novartis Investigative Site — Boston, Massachusetts, United States
- Novartis Investigative Site — Boston, Massachusetts, United States
- Novartis Investigative Site — Boston, Massachusetts, United States
- Novartis Investigative Site — Rochester, Minnesota, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — Omaha, Nebraska, United States
- Novartis Investigative Site — Minneola, New York, United States
- Novartis Investigative Site — New York, New York, United States
- Novartis Investigative Site — New York, New York, United States
- Novartis Investigative Site — Durham, North Carolina, United States
- Novartis Investigative Site — Cincinnati, Ohio, United States
- Novartis Investigative Site — Cleveland, Ohio, United States
- Novartis Investigative Site — Cleveland, Ohio, United States
- Novartis Investigative Site — Oklahoma City, Oklahoma, United States
- Novartis Investigative Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.